Follow us on Twitter for more news.Follow @mgh_mpec
December 1, 2020
Dr. Mark Siedner and global colleagues report sobering data that drug resistance to older HIV drugs might also threaten the success of the newest treatment regimen.
Image courtesy of Siedner MJ et al. (2020). Reduced efficacy of HIV-1 integrase inhibitors in patients with drug resistance mutations in reverse transcriptase. Nature Communications. https://doi.org/10.1038/s41467-020-19801-x.
November 13, 2020
Dr. Krishna Reddy and colleagues find that active case finding and isolation could control COVID-19 spread and save lives while being cost-effective in South Africa.
Image courtesy of Reddy KP et al. (2020). Cost-effectiveness of public health strategies for COVID-19 epidemic control in South Africa: a microsimulation modelling study. Lancet Global Health. https://doi.org/10.1016/S2214-109X(20)30452-6.
August 5, 2020
Dr. Anne Neilan discusses the clinical benefit and cost-effectiveness of quarterly HIV testing for high-risk young men who have sex with men in the U.S.
Image courtesy of Neilan AM et al. (2020). Cost-effectiveness of frequent HIV screening among high-risk young men who have sex with men in the United States. Clinical Infectious Diseases, ciaa1061. https://doi.org/10.1093/cid/ciaa1061.
July 27, 2020
Dr. Yuvaram Reddy and colleagues report findings from models that project shortages in continuous kidney replacement therapy (CKRT) during the COVID-19 pandemic.
Image courtesy of Reddy YN et al. (2020). Estimating shortages in capacity to deliver continuous kidney replacement therapy during the COVID-19 pandemic in the United States. American Journal of Kidney Diseases. https://doi.org/10.1053/j.ajkd.2020.07.005.
February 20, 2020
Dr. Ingrid Bassett discusses a new initiative to provide women in South Africa with contraception and PrEP services in hair salons.
Rochelle Walensky, MD, MPH, chief of the Division of Infectious Disease discusses her congressional testimony, public health advocacy and the challenges of infectious diseases.